Oncogenic Features in Histologically Normal Mucosa: Novel Insights Into Field Effect From a Mega-Analysis of Colorectal Transcriptomes.


Journal

Clinical and translational gastroenterology
ISSN: 2155-384X
Titre abrégé: Clin Transl Gastroenterol
Pays: United States
ID NLM: 101532142

Informations de publication

Date de publication:
07 2020
Historique:
entrez: 9 8 2020
pubmed: 9 8 2020
medline: 9 9 2021
Statut: ppublish

Résumé

Colorectal cancer is a common malignancy that can be cured when detected early, but recurrence among survivors is a persistent risk. A field effect of cancer in the colon has been reported and could have implications for surveillance, but studies to date have been limited. A joint analysis of pooled transcriptomic data from all available bulk RNA-sequencing data sets of healthy, histologically normal tumor-adjacent, and tumor tissues was performed to provide an unbiased assessment of field effect. A novel bulk RNA-sequencing data set from biopsies of nondiseased colon from screening colonoscopy along with published data sets from the Genomic Data Commons and Sequence Read Archive were considered for inclusion. Analyses were limited to samples with a quantified read depth of at least 10 million reads. Transcript abundance was estimated with Salmon, and downstream analysis was performed in R. A total of 1,139 samples were analyzed in 3 cohorts. The primary cohort consisted of 834 independent samples from 8 independent data sets, including 462 healthy, 61 tumor-adjacent, and 311 tumor samples. Tumor-adjacent gene expression was found to represent an intermediate state between healthy and tumor expression. Among differentially expressed genes in tumor-adjacent samples, 1,143 were expressed in patterns similar to tumor samples, and these genes were enriched for cancer-associated pathways. Novel insights into the field effect in colorectal cancer were generated in this mega-analysis of the colorectal transcriptome. Oncogenic features that might help explain metachronous lesions in cancer survivors and could be used for surveillance and risk stratification were identified.

Identifiants

pubmed: 32764205
doi: 10.14309/ctg.0000000000000210
pii: 01720094-202007000-00007
pmc: PMC7386360
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00210

Subventions

Organisme : NCI NIH HHS
ID : R01 CA143237
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA163177
Pays : United States

Références

Front Oncol. 2015 Feb 02;5:19
pubmed: 25699240
Mol Cancer. 2014 Mar 05;13:46
pubmed: 24597571
Front Oncol. 2018 Nov 08;8:474
pubmed: 30467535
Gastroenterology. 2006 Sep;131(3):830-40
pubmed: 16952552
Biostatistics. 2016 Jan;17(1):29-39
pubmed: 26272994
Bioinformatics. 2018 Aug 15;34(16):2867-2869
pubmed: 29608647
Dis Colon Rectum. 2012 May;55(5):522-31
pubmed: 22513430
J Natl Cancer Inst. 2005 Sep 21;97(18):1330-8
pubmed: 16174854
Sci Rep. 2018 Dec 5;8(1):17639
pubmed: 30518951
Cancer Res. 2003 Apr 15;63(8):1727-30
pubmed: 12702551
J Gastroenterol Hepatol. 2013 Jun;28(6):967-74
pubmed: 23425061
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Clin Oncol. 2008 Apr 1;26(10):1626-34
pubmed: 18316791
Scand J Surg. 2019 Jun;108(2):152-158
pubmed: 30196753
Nat Genet. 2012 May 06;44(6):699-703
pubmed: 22561515
Nature. 2014 Aug 7;512(7512):87-90
pubmed: 25079323
Bioinformatics. 2014 Feb 01;30(3):301-4
pubmed: 24319002
J Carcinog. 2011 Mar 17;10:6
pubmed: 21483654
Mod Pathol. 2015 Jan;28(1):14-29
pubmed: 24925058
Gastroenterology. 2016 Mar;150(3):758-768.e11
pubmed: 26892199
Gastroenterology. 2019 Apr;156(5):1309-1323.e3
pubmed: 30553914
Cell Oncol (Dordr). 2011 Aug;34(4):315-26
pubmed: 21573932
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Genomics. 2014 Feb-Mar;103(2-3):211-21
pubmed: 24316131
Gastroenterology. 2012 Apr;142(4):855-864.e8
pubmed: 22178590
PLoS One. 2016 Jul 21;11(7):e0159899
pubmed: 27442508
Science. 2017 Aug 18;357(6352):
pubmed: 28818916
Cancer. 1953 Sep;6(5):963-8
pubmed: 13094644
J Cell Biol. 2007 Aug 13;178(4):635-48
pubmed: 17698607
Genome Biol. 2018 Sep 25;19(1):142
pubmed: 30253799
Nat Commun. 2017 Oct 20;8(1):1077
pubmed: 29057876
Sci Data. 2018 Apr 17;5:180061
pubmed: 29664468
Nat Methods. 2015 Feb;12(2):115-21
pubmed: 25633503
PLoS Genet. 2007 Sep;3(9):1724-35
pubmed: 17907809

Auteurs

Christopher H Dampier (CH)

Department of Surgery, University of Virginia, Charlottesville, Virginia, USA.
Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.

Matthew Devall (M)

Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.
Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.

Lucas T Jennelle (LT)

Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.
Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.

Virginia Díez-Obrero (V)

Department of Surgery, University of Virginia, Charlottesville, Virginia, USA.
Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.
Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.
Oncology Data Analytics Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
Unit of Biomarkers and Susceptibility, ICO, L'Hospitalet de Llobregat, Barcelona, Spain.

Sarah J Plummer (SJ)

Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.
Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.

Victor Moreno (V)

Department of Surgery, University of Virginia, Charlottesville, Virginia, USA.
Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.
Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.
Oncology Data Analytics Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
Unit of Biomarkers and Susceptibility, ICO, L'Hospitalet de Llobregat, Barcelona, Spain.

Graham Casey (G)

Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.
Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH